209 related articles for article (PubMed ID: 34048186)
1. The Platelet to Lymphocyte and Neutrophil to Lymphocyte Ratios in Predicting Response to Platinum-based Chemotherapy for Epithelial Ovarian Cancer.
Winarno GNA; Pasaribu M; Susanto H; Nisa AS; Harsono AB; Yuseran H; Suardi D; Trianasari N
Asian Pac J Cancer Prev; 2021 May; 22(5):1561-1566. PubMed ID: 34048186
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
Miao Y; Yan Q; Li S; Li B; Feng Y
Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
[TBL] [Abstract][Full Text] [Related]
3. Possible surrogate marker for an effective dose-dense chemotherapy in treating ovarian cancer.
Huang CY; Yang YC; Wang KL; Chen TC; Chen JR; Weng CS; Chien HJ; Chang CL
Taiwan J Obstet Gynecol; 2016 Jun; 55(3):405-9. PubMed ID: 27343324
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil to lymphocyte and platelet to lymphocyte ratios increase in ovarian tumors in the presence of frank stromal invasion.
Polat M; Senol T; Ozkaya E; Ogurlu Pakay G; Cikman MS; Konukcu B; Ozten MA; Karateke A
Clin Transl Oncol; 2016 May; 18(5):457-63. PubMed ID: 26289552
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of neutrophil-to-lymphocyte ratio in early-stage ovarian clear-cell carcinoma.
Yoshida K; Yoshikawa N; Shirakawa A; Niimi K; Suzuki S; Kajiyama H; Kikkawa F
J Gynecol Oncol; 2019 Nov; 30(6):e85. PubMed ID: 31576683
[TBL] [Abstract][Full Text] [Related]
6. Comparison of neutrophil/lymphocyte and platelet/ lymphocyte ratios for predicting malignant potential of suspicious ovarian masses in gynecology practice.
Topcu HO; Guzel AI; Ozer I; Kokanali MK; Gokturk U; Muftuoglu KH; Doganay M
Asian Pac J Cancer Prev; 2014; 15(15):6239-41. PubMed ID: 25124604
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of The Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Platelet Count for Platinum-Sensitive Recurrent Epithelial Ovarian Cancer.
Sowannakul A; Rodpenpear N; Ekbhum P; Tantitamit T
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3765-3771. PubMed ID: 38019234
[TBL] [Abstract][Full Text] [Related]
8. Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer.
Huang Z; Liu Y; Yang C; Li X; Pan C; Rao J; Li N; Liao W; Lin L
BMC Cancer; 2018 May; 18(1):515. PubMed ID: 29720123
[TBL] [Abstract][Full Text] [Related]
9. Association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with ER and PR in breast cancer patients and their changes after neoadjuvant chemotherapy.
Xu J; Ni C; Ma C; Zhang L; Jing X; Li C; Liu Y; Qu X
Clin Transl Oncol; 2017 Aug; 19(8):989-996. PubMed ID: 28247194
[TBL] [Abstract][Full Text] [Related]
10. Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
Graziano V; Grassadonia A; Iezzi L; Vici P; Pizzuti L; Barba M; Quinzii A; Camplese A; Di Marino P; Peri M; Veschi S; Alberti S; Gamucci T; Di Gioacchino M; De Tursi M; Natoli C; Tinari N
Breast; 2019 Apr; 44():33-38. PubMed ID: 30611095
[TBL] [Abstract][Full Text] [Related]
11. Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications.
Chen W; Zhong S; Shan B; Zhou S; Wu X; Yang H; Ye S
J Ovarian Res; 2020 Aug; 13(1):89. PubMed ID: 32771026
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Baseline Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Local and Advanced Gastric Cancer Patients.
Aldemir MN; Turkeli M; Simsek M; Yildirim N; Bilen Y; Yetimoglu H; Bilici M; Tekin SB
Asian Pac J Cancer Prev; 2015; 16(14):5933-7. PubMed ID: 26320475
[TBL] [Abstract][Full Text] [Related]
13. May the platelet to lymphocyte ratio be a prognostic factor for epithelial ovarian cancer?
Kokcu A; Kurtoglu E; Celik H; Tosun M; Malatyalıoglu E; Ozdemir AZ
Asian Pac J Cancer Prev; 2014; 15(22):9781-4. PubMed ID: 25520104
[TBL] [Abstract][Full Text] [Related]
14. Prognostic roles of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in ovarian cancer: a meta-analysis of retrospective studies.
Zhao Z; Zhao X; Lu J; Xue J; Liu P; Mao H
Arch Gynecol Obstet; 2018 Apr; 297(4):849-857. PubMed ID: 29368160
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of preoperative inflammatory markers and serum CA 125 level for surgical outcome in Indonesian women with epithelial ovarian cancer.
Sastra WIG; Aditya PPK; Gradiyanto OE; Ketut S
Cancer Biomark; 2022; 34(1):123-129. PubMed ID: 34806598
[TBL] [Abstract][Full Text] [Related]
16. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer.
Lian L; Xia YY; Zhou C; Shen XM; Li XL; Han SG; Zheng Y; Mao ZQ; Gong FR; Wu MY; Chen K; Tao M; Li W
Cancer Biomark; 2015; 15(6):899-907. PubMed ID: 26444485
[TBL] [Abstract][Full Text] [Related]
17. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy.
Liontos M; Andrikopoulou A; Koutsoukos K; Markellos C; Skafida E; Fiste O; Kaparelou M; Thomakos N; Haidopoulos D; Rodolakis A; Dimopoulos MA; Zagouri F
J Ovarian Res; 2021 Nov; 14(1):148. PubMed ID: 34724958
[TBL] [Abstract][Full Text] [Related]
19. Investigating Preoperative Hematologic Markers for Prediction of Ovarian Cancer Surgical Outcome.
Ashrafganjoei T; Mohamadianamiri M; Farzaneh F; Hosseini MS; Arab M
Asian Pac J Cancer Prev; 2016; 17(3):1445-8. PubMed ID: 27039787
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer.
Cho KM; Park H; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
Oncotarget; 2017 Jan; 8(2):2329-2341. PubMed ID: 27911876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]